Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Optimizing the use of CROs by academia and small companies.

Lane RF, Friedman LG, Keith C, Braithwaite SP, Frearson JA, Lowe DA, Longo FM, Refolo LM, Watterson DM, Tsaioun K, Shineman DW, Fillit HM.

Nat Rev Drug Discov. 2013 Jul;12(7):487-8. doi: 10.1038/nrd4057. No abstract available.

PMID:
23812255
2.

Safety of medicine and the use of animals in research.

Archibald K, Baxter AD, BéruBé K, Bunton D, Clotworthy M, Coleman B, Foster CS, Hillier C, McFarlane M, Patel A, Pierscionek B, Root J, Thomas G, Tsaioun K, Wilkinson JM, Wilmut I, Wright KL.

Lancet. 2011 Oct 29;378(9802):e2. doi: 10.1016/S0140-6736(11)61669-3. No abstract available.

PMID:
22035557
3.

QSAR-based permeability model for drug-like compounds.

Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A.

Bioorg Med Chem. 2011 Apr 15;19(8):2615-24. doi: 10.1016/j.bmc.2011.03.011. Epub 2011 Mar 12.

PMID:
21458999
4.

De-risking drug discovery with ADDME -- avoiding drug development mistakes early.

Tsaioun K, Jacewicz M.

Altern Lab Anim. 2009 Sep;37 Suppl 1:47-55. Review.

5.

ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective.

Tsaioun K, Bottlaender M, Mabondzo A; Alzheimer's Drug Discovery Foundation.

BMC Neurol. 2009 Jun 12;9 Suppl 1:S1. doi: 10.1186/1471-2377-9-S1-S1. Review.

6.

Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.

Gwathmey JK, Tsaioun K, Hajjar RJ.

Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):647-60. doi: 10.1517/17425250902932915. Review.

PMID:
19442031
7.

Vitamin K-dependent proteins in the developing and aging nervous system.

Tsaioun KI.

Nutr Rev. 1999 Aug;57(8):231-40. Review.

PMID:
10518409
8.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk